It is becoming increasingly clear that tumour cells must be studied in the context of their 3D tissue microenvironment to obtain accurate information about their biology and identify relevant drug targets. Ridky et al. describe a new 3D in vitro model of invasive neoplasia that can be derived using the four stratified squamous epithelia that are associated with human cancer: epidermis, oropharynx, oesophagus and cervix. The authors transformed the epithelia by inducing tumour-associated signalling pathways and then cultured them with an intact basement membrane supported by cell-populated living stroma. This multi-tissue model recapitulated many features of in vivo tumour progression, including epithelial invasion of the basement membrane. Gene-expression profiling provided further support that the system faithfully models human epithelial cancer, and inhibitor studies indicate that it could be used to screen for new therapeutics, including those that target the tumour microenvironment.
Invasive human epithelial neoplasia in 3D
Invasive human epithelial neoplasia in 3D. Dis Model Mech 1 January 2011; 4 (1): 2. doi:
Download citation file:
Advertisement
Cited by
New Special Issue: Translating Multiscale Research in Rare Disease. Edited by Monica Justice, Monkol Lek, Karen Liu and Kate Rauen.
This special issue features original Research, Resources & Methods and Review-type articles that aim to interrogate the mechanisms of rare diseases to foster meaningful clinical progress in their diagnosis and treatment.
The role of the International Society for Stem Cell Research (ISSCR) guidelines in disease modelling
The ISSCR provides comprehensive guidelines and standards for using human stem cells in biomedical research. In this Editorial, Cody Juguilon and Joseph Wu discuss how and why these should be incorporated in disease modelling research.
Subject collection: Building advocacy into research
DMM’s series - Building advocacy into research - features interviews, ‘The Patient’s Voice’, with patients and advocates for a range of disease types, with the aim of supporting the highest quality research for the benefit of all patients affected by disease.
Read & Publish Open Access publishing: what authors say
We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
Biologists @ 100 - join us in Liverpool in March 2025
We are excited to invite you to a unique scientific conference, celebrating the 100-year anniversary of The Company of Biologists, and bringing together our different communities. The conference will incorporate the Spring Meetings of the BSCB and the BSDB, the JEB Symposium Sensory Perception in a Changing World and a DMM programme on antimicrobial resistance. Find out more and register your interest to join us in March 2025 in Liverpool, UK.
Other journals from
The Company of Biologists